Krenning EP - Search Results

1

Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.

Teunissen JJ, Kwekkeboom DJ, de Jong M, Esser JP, Valkema R, Krenning EP. Teunissen JJ, et al. Among authors: krenning ep. Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):595-616. doi: 10.1016/j.bpg.2005.04.001. Best Pract Res Clin Gastroenterol. 2005. PMID: 16183530 Review.

2

New advances in peptide receptor radionuclide therapy.

de Jong M, Krenning E. de Jong M, et al. J Nucl Med. 2002 May;43(5):617-20. J Nucl Med. 2002. PMID: 11994523 Free article. No abstract available.

3

111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.

Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M. Capello A, et al. Eur J Nucl Med Mol Imaging. 2005 Nov;32(11):1288-95. doi: 10.1007/s00259-005-1877-x. Epub 2005 Jul 15. Eur J Nucl Med Mol Imaging. 2005. PMID: 16021448

4

Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function.

Teunissen JJ, Krenning EP, de Jong FH, de Rijke YB, Feelders RA, van Aken MO, de Herder WW, Kwekkeboom DJ. Teunissen JJ, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1758-66. doi: 10.1007/s00259-009-1151-8. Epub 2009 May 27. Eur J Nucl Med Mol Imaging. 2009. PMID: 19471926 Free PMC article.

5

Peptide-receptor radionuclide therapy for endocrine tumors.

van Essen M, Krenning EP, Kam BL, de Jong M, Valkema R, Kwekkeboom DJ. van Essen M, et al. Among authors: krenning ep. Nat Rev Endocrinol. 2009 Jul;5(7):382-93. doi: 10.1038/nrendo.2009.105. Epub 2009 Jun 2. Nat Rev Endocrinol. 2009. PMID: 19488074 Review.

6

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.

Kwekkeboom DJ, Krenning EP, Lebtahi R, Komminoth P, Kos-Kudła B, de Herder WW, Plöckinger U; Mallorca Consensus Conference participants; European Neuroendocrine Tumor Society. Kwekkeboom DJ, et al. Among authors: krenning ep. Neuroendocrinology. 2009;90(2):220-6. doi: 10.1159/000225951. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19713714

7

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues.

Rolleman EJ, Melis M, Valkema R, Boerman OC, Krenning EP, de Jong M. Rolleman EJ, et al. Among authors: krenning ep. Eur J Nucl Med Mol Imaging. 2010 May;37(5):1018-31. doi: 10.1007/s00259-009-1282-y. Epub 2009 Nov 14. Eur J Nucl Med Mol Imaging. 2010. PMID: 19915842 Review.

8

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP. Kwekkeboom DJ, et al. Among authors: krenning ep. Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73. doi: 10.1677/ERC-09-0078. Print 2010 Mar. Endocr Relat Cancer. 2010. PMID: 19995807 Review.

9

Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.

Kwekkeboom DJ, de Herder WW, van Eijck CH, Kam BL, van Essen M, Teunissen JJ, Krenning EP. Kwekkeboom DJ, et al. Among authors: krenning ep. Semin Nucl Med. 2010 Mar;40(2):78-88. doi: 10.1053/j.semnuclmed.2009.10.004. Semin Nucl Med. 2010. PMID: 20113677 Review.

10

Preclinical and clinical studies of peptide receptor radionuclide therapy.

Pool SE, Krenning EP, Koning GA, van Eijck CH, Teunissen JJ, Kam B, Valkema R, Kwekkeboom DJ, de Jong M. Pool SE, et al. Among authors: krenning ep. Semin Nucl Med. 2010 May;40(3):209-18. doi: 10.1053/j.semnuclmed.2009.12.001. Semin Nucl Med. 2010. PMID: 20350630 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

461 results

Search Page